Thomas Denny
Professor of Medicine and Global Health
Thomas Denny
Professor of Medicine and Global Health
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory Medicine and Pediatrics, Associate Professor of Preventive Medicine and Community Health and Assistant Dean for Research in Health Policy at the New Jersey Medical School, Newark, New Jersey. He has served on numerous committees for the NIH over the last two decades and currently is the principal investigator of an NIH portfolio in excess of 56 million dollars. Mr. Denny was a 2002-2003 Robert Wood Johnson Foundation Health Policy Fellow at the Institute of Medicine of the National Academies (IOM). As a fellow, he served on the US Senate Health, Education, Labor and Pensions Committee with legislation/policy responsibilities in global AIDS, bioterrorism, clinical trials/human subject protection and vaccine related-issues.
Projects
-
EQAPOL (External Quality Assurance Proficiency of Laboratories)
United States
-
IVQAC - Immunology Virology Quality Assessment Center
United States
-
Vaccine and Treatment Evaluation Unit (VTEU)
United States
Publications
-
Giroux NS, Ding S, McClain MT, Burke TW, Petzold E, Chung HA, et al. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity. Biorxiv. 2020 Dec 5;
-
Polage CR, Lee MJ, Hubbard C, Rehder C, Cardona D, Denny T, et al. Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations. Jama Netw Open. 2020 Dec 1;3(12):e2031517.
-
Denny TN, Andrews L, Bonsignori M, Cavanaugh K, Datto MB, Deckard A, et al. Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020. Mmwr Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1743–7.
-
Hurst JH, Heston SM, Chambers HN, Cunningham HM, Price MJ, Suarez L, et al. SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. Clin Infect Dis. 2020 Nov 3;
-
See more publications at Scholars@Duke